Global /India /Healthcare /Drug Manufacturers - General /CURIS
chevron_leftBack
Curis Lifesciences Ltd. logo

Curis Lifesciences Ltd.

CURIS
NSE: CURIS Delayed
125.00INR 4.2%
1.31 USD
As of 13 June 2026, Curis Lifesciences Ltd. has a market cap of $10.17M USD, ranking #41193 globally and #3236 in India. It ranks #3662 in the Healthcare sector, and #1191 in the Drug Manufacturers - General industry.
Global Rank
41193
Country Rank
3236
Sector Rank
3662
Industry Rank
1191
Key Stats
Market Cap
$10.17MUSD
970.13M INR
Enterprise Value
$11.76MUSD
1.12B INR
Revenue (TTM)
$5.2MUSD
496.32M INR
EBITDA (TTM)
$1.05MUSD
100.37M INR
Net Income (TTM)
$640.21KUSD
61.05M INR
EBITDA Margin
20%
Profit Margin
12%
PE Ratio
11.7
PS Ratio
2.0
PB Ratio
6.0
EV/EBITDA
11.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dharmesh Patel open_in_new
Founded
2010
Website
curisls.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
4.2% 7.1% 30% 15% 0.9% -23%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
CURIS
ISIN: INE1BZN01016
Shares Out.:
8.084M1
TV:
SA:
YF:
GF:
BA:
MS:
125.00 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Curis Lifesciences Ltd.

Curis Lifesciences Limited operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India. The company's business model operates through loan license manufacturing, through which, the company carry outs manufacturing under Loan License arrangement for domestic suppliers, where all raw materials and excipients are procured and delivered by the client; contract manufacturing, where the company carry outs manufacturing under Contract Manufacturing arrangement for merchant exporters and domestic suppliers, where it would be responsible for procuring and handling all ingredients, raw materials, and packaging materials; and Direct Export/Own Brand Manufacturing, under which the company manufactures products registered by itself in foreign country and sells the said products in foreign country through its distribution. Curis Lifesciences Limited was founded in 2010 and is based in Sanand, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$44.75B
4.27T INR
440K%
39.1
DIVISLAB
$18.19B
1.73T INR
179K%
70.0
$15.01B
1.43T INR
147K%
63.0
$11.61B
1.11T INR
114K%
19.6
MANKIND
$9.77B
931.67B INR
96K%
52.2
ZYDUSLIFE
$9.61B
916.53B INR
94K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
7M%
38.1
JNJ
$547.28B
5M%
26.4
ABBV
$360.63B
4M%
97.4
$321.52B
256.25B CHF
3M%
19.9
AZN
$288.84B
215.59B GBP
3M%
27.6
NOVN
$274.65B
218.9B CHF
3M%
20.5
chevron_leftBack